Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Post by biorunon Oct 17, 2022 4:31pm
136 Views
Post# 35029966

why now?

why now?it's simply a super sale and a very brief moment in time to take a reasonable risk for a potentially significant reward. I say "potentially" because there is always risk with any entry point but the medium to long term potential is most definitely there - does it matter if its 16, 18, 24 or 36 cents or higher. its all decent gain potential. and because they are working on more than one pharmaceutical deals and have the other side at the table, the additional possibilities are not insignificant.

And nobody who feels completely disappointed so far should absolutely do anything here and pile on to your existing grief. I am very disappointed with the recent price, certainly, but I can see when it gets so stupid and there is a gap. I am buying now again - small amounts and will continue to do so while it is low.

so if you are planning on investing in the company as part of a longer term commitment, then why buy at 20 or 30 cents when you can buy now and get 2x to 3x the shares for the same investment?

all the emotions aside, we have been here before at least 3 times and its dead pan obvious it won't last, at least from my point of view.
<< Previous
Bullboard Posts
Next >>